Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Riveiro-Barciela M, Barreira-Díaz A, Vidal-González J, Muñoz-Couselo E, Martínez-Valle F, Viladomiu L, Mínguez B, Ortiz-Velez C, Castells L, Esteban R, Buti M.
Riveiro-Barciela M, et al.
Liver Int. 2020 Aug;40(8):1906-1916. doi: 10.1111/liv.14489. Epub 2020 Jun 3.
Liver Int. 2020.
PMID: 32329119